Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors

IMPORTANCE: Toxic effects of conventional chemotherapy and molecularly targeted cancer therapies are generally well defined and occur at predictable points. By contrast, owing to their heterogeneous manifestations, unpredictable timing, and clinical overlap with other conditions, immune-related adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiehchen, David, Watters, Mary K., Lu, Rong, Xie, Yang, Gerber, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751757/
https://www.ncbi.nlm.nih.gov/pubmed/31532516
http://dx.doi.org/10.1001/jamanetworkopen.2019.11519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751757/
https://www.ncbi.nlm.nih.gov/pubmed/31532516
http://dx.doi.org/10.1001/jamanetworkopen.2019.11519

Ejemplares similares